Literature DB >> 12921785

Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2.

Xin Du1, Fang-Ming Deng, Hitendra Singh Chand, Walter Kisiel.   

Abstract

Human tissue factor pathway inhibitor-2 (TFPI-2) is a matrix-associated Kunitz-type serine proteinase inhibitor that is secreted by all cells of the vasculature, and presumably plays a role in the regulation of plasmin-mediated matrix remodeling. In this report, we describe the cloning and expression of a full-length cDNA for bovine TFPI-2 that exhibits 72% sequence identity with that of human TFPI-2. Following a 22 residue signal peptide, the mature protein contains 212 amino acids with 18 cysteines, three putative N-glycosylation sites, and one putative O-glycosylation site. The deduced sequence of mature bovine TFPI-2 revealed a short acidic amino-terminal region, three tandem Kunitz-type domains, and a carboxy-terminal tail highly enriched in basic amino acids. Recombinant bovine TFPI-2 was expressed in HEK 293 cells and resolved into two isoforms, designated as alpha-TFPI-2 (M(r) 33 kDa) and beta-TFPI-2 (M(r) 31 kDa), which presumably represent differentially glycosylated forms of the inhibitor. Similar to human TFPI-2, both bovine TFPI-2 isoforms exhibited strong inhibitory activity towards trypsin and plasmin, and weak inhibitory activity towards the factor VIIa-tissue factor complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921785     DOI: 10.1016/s0003-9861(03)00332-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.

Authors:  Prakasha Kempaiah; Hitendra S Chand; Walter Kisiel
Journal:  Arch Biochem Biophys       Date:  2008-12-10       Impact factor: 4.013

2.  Identification of the Recombinant Plasmodium vivax Surface-Related Antigen as a Possible Immune Evasion Factor Against Human Splenic Fibroblasts by Targeting ITGB1.

Authors:  Haitian Fu; Jiachen Lu; Xinxin Zhang; Bo Wang; Yifan Sun; Yao Lei; Feihu Shen; Kokouvi Kassegne; Eun-Taek Han; Yang Cheng
Journal:  Front Cell Dev Biol       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.